15th Annual Clinical Trial Supply New England 2026

Arena will be returning to the Westin Waltham for our 2026 Clinical Trial Supply, New England conference. The event will showcase talks from top industry players, unrivaled networking opportunities and the chance to find cutting-edge solutions in the exhibition hall.

14 - 15

April

2026
  • The Westin Waltham Boston, MA, USA
  • Complimentary
  • Agenda
  • Advisory Board
  • Speakers
  • Plan Your Visit
  • Event Gallery
  • 2026 Sponsors
  • Media Centre
  • Why partner?
  • Contact Us
close

WHAT TO EXPECT FOR 2025?

The annual Clinical Trial Supply conference is a leading summit for discovering exclusive expert-led insight, featuring major bio-pharma companies including Alexion, Regeneron and Takeda.

The event will feature a mixture of presentations, fireside chats, panel discussions and roundtable discussions on the latest hot topics and trends within clinical supply.

The Clinical Trial Supply series is a unique platform for clinical trial sponsors and solution providers. It is aimed at enabling knowledge-sharing, benchmarking, network-building and forging partnerships and innovation amongst biopharma industry peers.

100+

Attendees

30+

Exhibitors

20+

Speakers

100+

Attendees

30+

Exhibitors

20+

Speakers

See What It's All About

Agenda

  • 14 Apr 2026
  • 15 Apr 2026
Expand All

8:15 AM

Registration and refreshments

8:50 AM

Chairperson’s opening remarks

Speakers

Paul Larochelle
Senior Director Global Clinical Supply Chain,
Takeda

9 AM

Performance & agility – How technology and AI can help us to push the limits

  • Agility & performance equilibrium explanation
  • Technology innovation from forecasting to operations
  • AI from basic automation to AI-powered insights and agents across the clinical supply chain

Speakers

Michael Klein
Therapeutic Area Group Head, Director, Clinical Supply Chain, Sanofi

9:30 AM

Reserved for event sponsor

10 AM

Tackling global trade compliance in clinical supply chain to meet regulations and avoid unnecessary delays

  • Valuation of clinical items moving through borders
  • HS/HTS codes for blinded clinical shipments versus clinical supplies moving to distribution sites
  • VAT expenses: how they apply, when and how they can be recovered
  • Sanctions and exemptions in the pharmaceutical industry
  • Overall best practices to approach your clinical studies from a customs perspective

Speakers

Matthew Leets
Associate Director, Global Trade Compliance, Strategic Sourcing

10:30 AM

Morning refreshments and networking

11 AM

Panel Discussion Building cross-functional alignment to navigate global trade challenges in clinical supply

  • Coordinating across regulatory, logistics, and compliance teams to ensure seamless global shipments
  • Anticipating geopolitical and policy shifts that impact trade routes and study timelines
  • Strengthening communication with regulators, CROs, and suppliers to reduce delays and risk exposure

Speakers

Paul Larochelle
Senior Director Global Clinical Supply Chain,
Takeda
Matthew Leets
Associate Director, Global Trade Compliance, Strategic Sourcing
Erika Vidal-Faulkenberry
Global Head Trade Compliance, Biogen
Quinn Parks
Director of Clinical Supply Chain, Mediar Therapeutics

11:30 AM

Reserved for event sponsor

12 PM

FIRESIDE CHAT Strengthening IRT capabilities for reliable and efficient clinical supply

  • Enhancing supply visibility and forecasting accuracy through effective IRT configuration
  • Streamlining resupply triggers, drug accountability, and site oversight to reduce delays
  • Improving cross-functional collaboration to optimise IRT workflows and prevent stockouts

Speakers

Kerri Raso
Director IRT Systems, Tango Therapeutics

12:30 PM

Reserved for event sponsor

12:45 PM

Lunch and networking

2 PM

Cutting clinical supply costs without compromising quality and compliance

  • Identifying hidden cost drivers across packaging, comparators, and logistics
  • Leveraging risk-based planning to reduce waste in over-forecasting and returns
  • Building cost-efficient partnerships with vendors while safeguarding trial timelines

Speakers

Francesco Santo
Director Clinical Supply Chain,
Orano Med

2:30 PM

Reserved for event sponsor

3 PM

Streamlining ancillary supply management to prevent hidden trial delays

  • Coordinating critical non-drug supplies (kits, lab equipment, PPE) alongside IP shipments
  • Leveraging forecasting tools to reduce waste and avoid shortages
  • Aligning ancillary supply logistics with global distribution strategies

Speakers

Kristin Prescott
Director, Centralized Ancillary and Commercial Drug Supply, Takeda

3:30 PM

Afternoon refreshments and networking

4 PM

Safeguarding cold chain integrity in an era of complex and global trials

  • Embedding digital temperature monitoring and real-time alerts to prevent costly excursions
  • Designing risk-based shipping strategies for advanced therapies and biologics
  • Building packaging solutions that protect product stability without driving up cost or waste

Speakers

Jim Marshall
Senior Director Head of Supply Chain, Elektrofi

4:30 PM

Reserved for event sponsor

5 PM

PANEL DISCUSSION Implementing best practices for outsourcing services through third party vendors

  • Selecting the right vendors to align with study and supply chain needs
  • Building strong vendor relationships to ensure quality and compliance
  • Monitoring performance and mitigating risks throughout the outsourcing process

Speakers

Paul Larochelle
Senior Director Global Clinical Supply Chain,
Takeda
Leticia Tarilonte
Vice President, Head of Global Clinical Operations, Pyxis Oncology
Andrea Bottkova
Director, Senior Director, Procurement and Vendor Management, Karyopharm Therapeutics Inc.

5:30 PM

Chairperson’s closing remarks

END OF DAY 1 AND NETWORKING DRINKS

8:15 AM

Registration and refreshments

8:50 AM

Chairperson’s opening remarks

Speakers

Paul Larochelle
Senior Director Global Clinical Supply Chain,
Takeda

9 AM

PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

During the roundtable discussion session, the conference hall will be divided into three ‘zones’. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within clinical supply chains. After 45 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

ROUNDTABLE 1: Developing comprehensive organizational approaches to interactive response technology (IRT) for efficient supply management

ROUNDTABLE 2: Exploring ways of advancing clinical trial supply with RPA, Advanced Analytics and Generative AI
Tomasz Adamusiak, Chief Scientist, Clinical Quality and Data Science, MITRE

ROUNDTABLE 3: TBC
US Customs and Border Protection Representative

Speakers

Tomasz Adamusiak
Chief Scientist, Clinical Quality and Data Science, MITRE

10:30 AM

Morning refreshments and networking

11:15 AM

Enhancing vendor sponsor collaboration when sourcing comparators

  • Avoiding common mistakes and applying mitigation strategies in comparator sourcing
  • Choosing the right comparator from the right manufacturer with confidence
  • Strengthening communication practices between vendor and sponsor for success

Reserved for Takeda representative

11:45 AM

Reserved for event sponsor (tech spotlight)

12 PM

Innovating clinical trial packaging and labeling for compliance and patient safety

  • Designing compliant multi-language labels across global regions
  • Balancing patient-centric packaging with regulatory requirements
  • Leveraging smart packaging & e-labeling to reduce errors and improve visibility

Speakers

Jessica Peterson
Supply Chain Lead, Pfizer

12:30 PM

FIRESIDE CHAT Building cross functional supply plans and agreements for stronger clinical supply chains

  • Establishing cross functional teams early to strengthen supply chain performance
  • Implementing agreements and team charters to support effective collaboration
  • Improving clinical supply chain management and trial timelines through alignment

Speakers

Tony Li
Associate Director, Clinical Supply Lead, Alexion

1 PM

Lunch and networking

2:15 PM

Implementing updated supply chain processes to improve and monitor sustainability

  • Introducing more sustainable procedures: where within the supply chain
  • Monitoring and measuring: how and with which tools
  • Sharing challenges and successes so far

Speakers

Maria Jo Lamberti
Research Associate Professor and Director, Sponsored Research, Tufts
Maria Florez
Senior Consultant, Tufts Center for the Study of Drug Development

2:45 PM

CTS sourcing and procurement trends and challenges – external manufacturing as the “procurement´s operational arm”

Accelerate, cultivate, innovate!

  • Managing relationships with the modern supplier
  • How Bayer's external relationship governance model adds value to the business ensuring a reliable partnership and complements the sourcing & procurement functions within CTS scope
  • Trends on procurement roles and the necessity to have an operational perspective
  • Different approaches from different business necessities
  • Trends on how to best manage CMOs, 3PLs and clinical trials partners

Speakers

Luiz Barberini
Head of External Manufacturing, Latin America, Bayer

3:15 PM

Panel Discussion Leveraging AI and digital tools to future-proof clinical supply

  • Exploring realistic AI applications across planning and distribution
  • Managing risks of automation while ensuring compliance
  • Sharing lessons learned from early adopters in the industry

Moderator
Paul Larochelle, Senior Director, Global Clinical Supply Chain, Takeda

Speakers

Paul Larochelle
Senior Director Global Clinical Supply Chain,
Takeda
Tomasz Adamusiak
Chief Scientist, Clinical Quality and Data Science, MITRE
Eyal Ron
Chief Technology Officer, Keyron LTD

4 PM

Chairperson’s closing remarks

Speakers

Paul Larochelle
Senior Director Global Clinical Supply Chain,
Takeda

END OF CONFERENCE

Speakers

Select a speaker to learn more

Back
Luiz Barberini
Head of External Manufacturing, Latin America, Bayer
  • Over 25 years’ experience in Logistics, Supply Chain, Procurement and Demand Planning areas.
    Solid knowledge and experience in the whole S&OP process and its KPI´s inter-relationships with stakeholders
  • Demand Planning process management - pre-S&OP, with Sales, Marketing, Trade Marketing, Industrial Planning and Finance and customized tool design for such process
  • Management skills: experience with multidisciplinary and international teams (Brazil / Latin America / US).
  • Experience in S&OP, 3PL and Supply Chain Organization projects' implementation
  • Strong experience with Pharmaceutical and Consumer companies and Brazilian distribution model / 3PL contracts
  • Solid team management skills, as well as Customer Service relationship and management
  • Teacher for major Post Graduation Schools - Demand Planning and Procurement/Negotiation areas

CSCP & CPIM APICS. Logistics & Supply Chain driven strategy. Distribution & Logistics, Demand Planning, S&OP, Procurement and Export experiences, focusing on Business necessities through effective leadership.

Working as External Manufacturing Operations Manager Latin America at Bayer, in charge for external partners for CHC Division. Previously as Relationship Associated Director at Merck , Logistics Manager at Takeda/Nycomed Pharma, focusing on demand management, planning and distribution activities. Also has worked as Pfizer´s Logistic Manager and EFD´s Supply Chain Manager. Souza Cruz´s Procurement Manager and Rhodia's Logistic Supervisor.

Specialties: Logistics, Supply Chain, Materials, Procurement , Services, Negotiation, 3PL contracts, S&OP, Demand Planning

Session Details:

CTS sourcing and procurement trends and challenges – external manufacturing as the “procurement´s operational arm”

2026-04-15, 2:45 PM

View In Agenda
Next speaker
Back
Matthew Leets
Associate Director, Global Trade Compliance, Strategic Sourcing

Matthew Leets holds a biology degree and has worked in pharma since 2013; the last 4 years have been in logistics and trade compliance.

Session Details:

Tackling global trade compliance in clinical supply chain to meet regulations and avoid unnecessary delays

2026-04-14, 10:00 AM

Session Details:

Panel Discussion Building cross-functional alignment to navigate global trade challenges in clinical supply

2026-04-14, 11:00 AM

View In Agenda
Next speaker
Back
Michael Klein
Therapeutic Area Group Head, Director, Clinical Supply Chain, Sanofi

Session Details:

Performance & agility – How technology and AI can help us to push the limits

2026-04-14, 9:00 AM

View In Agenda
Next speaker
Back
Jim Marshall
Senior Director Head of Supply Chain, Elektrofi

Session Details:

Safeguarding cold chain integrity in an era of complex and global trials

2026-04-14, 4:00 PM

View In Agenda
Next speaker
Back
Tony Li
Associate Director, Clinical Supply Lead, Alexion

Session Details:

FIRESIDE CHAT Building cross functional supply plans and agreements for stronger clinical supply chains

2026-04-15, 12:30 PM

View In Agenda
Next speaker
Back
Tomasz Adamusiak
Chief Scientist, Clinical Quality and Data Science, MITRE

Tomasz Adamusiak, MD PhD, serves as the Chief Scientist for Clinical Quality and Data Science at MITRE, where he leads initiatives to improve healthcare outcomes through AI and real-world evidence. Previously, as Head of Data Science at the Pfizer Innovation Research Lab, he led work on digital endpoints and decentralized clinical trials. He has held leadership positions within the American Medical Informatics Association and SNOMED International, and has published extensively in peer-reviewed journals.

Session Details:

PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

2026-04-15, 9:00 AM

Session Details:

Panel Discussion Leveraging AI and digital tools to future-proof clinical supply

2026-04-15, 3:15 PM

View In Agenda
Next speaker
Back
Paul Larochelle
Senior Director Global Clinical Supply Chain,
Takeda

Paul Larochelle currently serves as Senior Director (Planning Team Lead) for Global Clinical Supply Chain at Takeda, where he serves as a member of the GCSC Leadership Team and is responsible for managing a team of professionals overseeing the forecasting and planning of clinical study supplies. His role encompasses the strategic and operational aspects of clinical supply chain management in therapeutic areas such as oncology, neuroscience, gastrointestinal diseases, vaccines, and rare diseases. Paul's leadership extends to cross-functional projects aimed at implementing new capabilities, conducting due diligence of potential acquisitions by the company, and improving existing processes.

Previously, Paul held various roles at Biogen Corporation and Genzyme, a Sanofi Company, where he honed his expertise in clinical asset planning and clinical supplies management. His contributions to these organizations included serving as a lead contact for multiple clinical programs, developing supply chain strategies, leading continuous improvement projects, and serving as Fellowship Coordinator and Student Preceptor for dozens of students.

Paul has a BS in Biology from Providence College, PharmD from MCPHS Boston, and an MBA from Worcester Polytechnic Institute. He also completed a Post-PharmD Industry Fellowship in Clinical Research/Investigational Product Management with MCPHS-Worcester and Genzyme Corporation. He is Chair of the Dean's Advisory Board at MCPHS School of Pharmacy – Boston,  a member of the Pharmacy Advisory Board at Western New England University, and a member of the Advisory Board for the Clinical Trial Supply global conference series.

Session Details:

Chairperson’s opening remarks

2026-04-15, 8:50 AM

Session Details:

Panel Discussion Building cross-functional alignment to navigate global trade challenges in clinical supply

2026-04-14, 11:00 AM

Session Details:

Chairperson’s opening remarks

2026-04-14, 8:50 AM

Session Details:

Chairperson’s closing remarks

2026-04-15, 4:00 PM

Session Details:

PANEL DISCUSSION Implementing best practices for outsourcing services through third party vendors

2026-04-14, 5:00 PM

Session Details:

Panel Discussion Leveraging AI and digital tools to future-proof clinical supply

2026-04-15, 3:15 PM

View In Agenda
Next speaker
Back
Francesco Santo
Director Clinical Supply Chain,
Orano Med

A highly experienced and passionate Director Clinical Supply Chain, Francesco has dedicated the past 17 years to ensuring the seamless execution of clinical trials by optimizing supply chain operations. His deep commitment to this field is driven by a relentless pursuit of excellence in delivering life-saving treatments to patients worldwide.  Throughout his career, he has honed a diverse skill set, encompassing:

  • Strategic Supply Chain Management
  • Regulatory Compliance
  • Cross-Functional Collaboration
  • Risk Management
  • Innovative Problem-Solving

Francesco’s dedication to the clinical supplies industry is rooted in a profound understanding of the critical role it plays in advancing medical research and improving patient outcomes. He is committed to continuing his journey in this field, always striving to contribute to the betterment of global health.

Session Details:

Cutting clinical supply costs without compromising quality and compliance

2026-04-14, 2:00 PM

View In Agenda
Next speaker
Back
Mary Jo Lamberti
Research Associate Professor and Director, Sponsored Research, Tufts Center for the Study of Drug Development

Research Assistant Professor at Tufts University School of Medicine and Director of Sponsored Projects at Tufts CSDD.
Expertise in benchmarking drug development operating practices.
Research focus includes outsourcing and partnerships; clinical supplies; investigative site initiation and management; patient recruitment and retention; and the use of technologies and digital solutions in clinical trials.
Published extensively and is a frequent speaker at global conferences.
Current Initiatives Include:
• Study volunteer diversity in clinical trials
• Benchmarking patient recruitment and retention practices
• Industry use of automation, IT technologies and applications

Next speaker
Back
Maria Florez
Senior Consultant, Tufts Center for the Study of Drug Development

Maria Florez is involved in research looking at the impact of digital transformation in clinical research and organizational strategies and practices driving improvement in development operations and economics. Maria has been a researcher and strategist in the healthcare sector for 15 years. She has held positions at Cleveland Clinic and at New York-Presbyterian Hospital of Columbia and Cornell Universities and has published articles in trade and peer-reviewed journals. She holds a B.S. in economics and an M.A. in international economics from The Fletcher School of Law and Diplomacy at Tufts University.

Session Details:

Implementing updated supply chain processes to improve and monitor sustainability

2026-04-15, 2:15 PM

View In Agenda
Next speaker
Back
Leticia Tarilonte
Vice President, Head of Global Clinical Operations, Pyxis Oncology

Leticia has over 23 years of industry experience managing several research projects and clinical studies in various roles. She started her career in Pharma at Biogen, working collaboratively in an integrated monoclonal antibody research team and then moving to development in clinical operations, where she managed numerous phase I-III clinical trials in diverse therapeutic areas including, gastroenterology, immunology, neurology, and neuropathic pain.

She continued her career at Merck/EMD Serono where she provided strategic and operational expertise in the planning and conduct of several Phase I-III clinical studies in oncology and immuno-oncology, which led to the FDA accelerated approval of BAVENCIO® in merkel cell carcinoma and in urothelial carcinoma. Later she served as a Chief of Staff to the Sr. VP and Head of Development in Oncology, where she partnered with executive sponsors to identify and promote projects that are of strategic importance to the company and translating the function strategy into operational plans.
After many years in big Pharma, Leticia continued her career at various biotech companies: first at Kiniksa Pharmaceuticals, where she was responsible for various programs with high complexity in rare diseases, consisting of numerous global clinical trials in 10 different indications. Followed by Black Diamond Therapeutics, a biotech company addressing the significant unmet need for novel precision oncology therapies for patients with genetically defined cancers. In her last role, Leticia served as the Clinical Operations Lead at Nimbus Therapeutics, a biotech company working on the development of a HPK1 inhibitor in solid tumors.

Leticia also serves as an IRB Member at Yale University and is the Chair and President of the Association of Clinical Research Professionals (ACRP) - New England Chapter.
Leticia earned her Bachelor’s Degree in Biomedical Laboratory and Clinical Sciences from the School of Medicine at Boston University, followed by a Master’s Degree in Regulatory Affairs and Health Policy from the Massachusetts College of Pharmacy and Health Sciences in Boston.

Session Details:

PANEL DISCUSSION Implementing best practices for outsourcing services through third party vendors

2026-04-14, 5:00 PM

View In Agenda
Next speaker
Back
Kristin Prescott
Director, Centralized Ancillary and Commercial Drug Supply, Takeda

Session Details:

Streamlining ancillary supply management to prevent hidden trial delays

2026-04-14, 3:00 PM

View In Agenda
Next speaker
Back
Andrea Bottkova
Director, Senior Director, Procurement and Vendor Management, Karyopharm Therapeutics Inc.

I currently work as Senior Director of Procurement and Vendor Management at Karyopharm Therapeutics Inc. I have been negotiating contracts for little over fifteen years. Working 10 years in the biotech industry I have gained an excellent Understanding of all areas of research and development. In 2019 I helped establish Karyopharm’ s vendor management and procurement department to support vendor oversight, strategic sourcing maximizing financial savings. I am passionate about building partnerships and negotiating business terms of contracts resulting in several million dollar savings annually. I believe that I have perfected my negotiations skills while learning from my very curious 7-year-old son Barton.

Session Details:

PANEL DISCUSSION Implementing best practices for outsourcing services through third party vendors

2026-04-14, 5:00 PM

View In Agenda
Next speaker
Back
Eyal Ron
Chief Technology Officer, Keyron LTD

Session Details:

Panel Discussion Leveraging AI and digital tools to future-proof clinical supply

2026-04-15, 3:15 PM

View In Agenda
Next speaker
Back
Kerri Raso
Director IRT Systems, Tango Therapeutics

Session Details:

FIRESIDE CHAT Strengthening IRT capabilities for reliable and efficient clinical supply

2026-04-14, 12:00 PM

View In Agenda
Next speaker
Back
Erika Vidal-Faulkenberry
Global Head Trade Compliance, Biogen

Session Details:

Panel Discussion Building cross-functional alignment to navigate global trade challenges in clinical supply

2026-04-14, 11:00 AM

View In Agenda
Next speaker
Back
Quinn Parks
Director of Clinical Supply Chain, Mediar Therapeutics

Session Details:

Panel Discussion Building cross-functional alignment to navigate global trade challenges in clinical supply

2026-04-14, 11:00 AM

View In Agenda
Next speaker

Advisory Board

Select a member to learn more

Back
Chris Wallace
Head of Distribution EMEA, Argenx

Chris has over 35 years’ varied supply chain experience, having worked for several blue chip companies in a number of industries including 3rd party logistics services, automotive, medical device, nuclear fuels and biotech/pharmaceuticals.

Originally from the UK but now based in Switzerland, he has been involved in life science - biotech/pharmaceuticals & medical device - for over 20 years of his career and has latterly been SVP Global Supply Chain at Clover Biopharmaceutical before last year moving to Argenx as Head of Distribution EMEA.

He has developed, implemented and managed global healthcare supply chain strategies and operations on 6 continents. This has included different set-ups in multiple countries, including many in the Emerging Markets as well as the developed world.

Chris has a degree in economics from Manchester University, an MBA from Aston University and a postgraduate diploma from London University. In his spare time, he plays golf badly and loves to sample great Italian food and red wines!

Next
Back
Luiz Barberini
Head of External Manufacturing, Latin America, Bayer
  • Over 25 years’ experience in Logistics, Supply Chain, Procurement and Demand Planning areas.
    Solid knowledge and experience in the whole S&OP process and its KPI´s inter-relationships with stakeholders
  • Demand Planning process management - pre-S&OP, with Sales, Marketing, Trade Marketing, Industrial Planning and Finance and customized tool design for such process
  • Management skills: experience with multidisciplinary and international teams (Brazil / Latin America / US).
  • Experience in S&OP, 3PL and Supply Chain Organization projects' implementation
  • Strong experience with Pharmaceutical and Consumer companies and Brazilian distribution model / 3PL contracts
  • Solid team management skills, as well as Customer Service relationship and management
  • Teacher for major Post Graduation Schools - Demand Planning and Procurement/Negotiation areas

CSCP & CPIM APICS. Logistics & Supply Chain driven strategy. Distribution & Logistics, Demand Planning, S&OP, Procurement and Export experiences, focusing on Business necessities through effective leadership.

Working as External Manufacturing Operations Manager Latin America at Bayer, in charge for external partners for CHC Division. Previously as Relationship Associated Director at Merck , Logistics Manager at Takeda/Nycomed Pharma, focusing on demand management, planning and distribution activities. Also has worked as Pfizer´s Logistic Manager and EFD´s Supply Chain Manager. Souza Cruz´s Procurement Manager and Rhodia's Logistic Supervisor.

Specialties: Logistics, Supply Chain, Materials, Procurement , Services, Negotiation, 3PL contracts, S&OP, Demand Planning

Session Details:

CTS sourcing and procurement trends and challenges – external manufacturing as the “procurement´s operational arm”

2026-04-15, 2:45 PM

View In Agenda
Next
Back
Amanda Briceno
Clinical Supply Management & Patient Centricity Unit Manager, Chiesi Farmaceutici

Amanda Briceno is an experienced clinical supply professional with over 10 years in clinical research and supply chain operations. Originally from Venezuela, now based in Italy. She currently serves as Clinical Supply Manager and Head of the Patient Centricity Unit at Chiesi Farmaceutici, where she leads initiatives to design and deliver patient-focused clinical supply solutions that improve trial compliance and enhance the experience of both patients and site staff.

Her career began as a Clinical Research Associate at IQVIA, where she gained extensive experience in global trial monitoring and operations. Since joining Chiesi, Amanda has held positions of increasing responsibility within the Clinical Supply department, before assuming her current leadership role.

Amanda holds a Master’s degree in Drug Biotechnology from the Università degli Studi di Milano and a Bachelor’s degree in Medical Biotechnology. Amanda brings a strong blend of technical knowledge and operational leadership. Passionate about innovation in clinical supplies, she is dedicated to advancing more accessible, patient-centric clinical trials.

Next
Back
Paul Hingst
Supply Chain Consultant, Crinetics Pharmaceuticals

Paul is an experienced Clinical Supply Chain Professional with a 25-year career in the BioPharmaceutical industry.  His extensive career includes roles at major companies like Amgen and Thermo Fisher Scientific, where he honed his skills and made a significant impact.  He has served in varied roles from basic research and contract manufacturing to client services and account management.  He is a Principal Consultant and Co-Founder of Beacon BioPharm Associates, a clinical supply chain consulting firm, providing variable staffing solutions to small and mid-sized BioPharm clients.  Paul is an industry veteran and respected leader known for his expertise in clinical supply chain.

Next
Back
Amaury Jeandrain
Strategy Advisor, Clinical Supply, N-SIDE

Amaury Jeandrain has a Master’s Degree in Business Engineering with a specialization in supply chain optimization. He joined Clinigen in 2015, then N-SIDE in 2016 where he last  held the position of VP of Strategy for clinical supply solutions.

Over the past decade, his objective has been to make clinical trial supply chains more efficient by redefining CTS strategies and driving measurable performance improvements. His expertise also includes forecasting, planning, waste reduction, and shortage risk mitigation.

Since 2024, while accompanying his wife on humanitarian missions abroad (Niger, then Colombia), Amaury has continued his work as a CTS advisor and trainer, partnering with pharmaceutical companies worldwide to enhance clinical supply performance.

Next
Back
Francesco Santo
Director Clinical Supply Chain,
Orano Med

A highly experienced and passionate Director Clinical Supply Chain, Francesco has dedicated the past 17 years to ensuring the seamless execution of clinical trials by optimizing supply chain operations. His deep commitment to this field is driven by a relentless pursuit of excellence in delivering life-saving treatments to patients worldwide.  Throughout his career, he has honed a diverse skill set, encompassing:

  • Strategic Supply Chain Management
  • Regulatory Compliance
  • Cross-Functional Collaboration
  • Risk Management
  • Innovative Problem-Solving

Francesco’s dedication to the clinical supplies industry is rooted in a profound understanding of the critical role it plays in advancing medical research and improving patient outcomes. He is committed to continuing his journey in this field, always striving to contribute to the betterment of global health.

Session Details:

Cutting clinical supply costs without compromising quality and compliance

2026-04-14, 2:00 PM

View In Agenda
Next
Back
Arnaud Dourlens
Global Head of Clinical Supply Chain Operations, Sanofi

Arnaud Dourlens is an Arts et Métiers engineer, he began his industrial career in the FMCG sector where he held growing responsibilities. Then he joined the LVMH group where he reorganized new product launches and industrial investments in the Make-up segment in order to adapt to the need for innovation and time to market, thus providing a competitive advantage. He then managed the entire portfolio of industrial launches and investments in Perfumes, Skincare and Make-up for Parfums Christian Dior Group.

During his career Arnaud held a wide variety of industrial roles. He joined Sanofi in 2017 as Production Director of a major solid oral form production site (>2.5 billion € turnover). He has been a key player in the development of the continuous improvement mindset and in the transformation of the site through IT projects, investments and activity growth following the acquisition of Boehringer Ingelheim consumer healthcare portfolio.

Since the beginning of 2020, he’s been the global head of Sanofi Clinical Supply Chain Operations, managing worldwide clinical supply teams involved in more than 300 clinical studies.

Next
Back
Paul Larochelle
Senior Director Global Clinical Supply Chain,
Takeda

Paul Larochelle currently serves as Senior Director (Planning Team Lead) for Global Clinical Supply Chain at Takeda, where he serves as a member of the GCSC Leadership Team and is responsible for managing a team of professionals overseeing the forecasting and planning of clinical study supplies. His role encompasses the strategic and operational aspects of clinical supply chain management in therapeutic areas such as oncology, neuroscience, gastrointestinal diseases, vaccines, and rare diseases. Paul's leadership extends to cross-functional projects aimed at implementing new capabilities, conducting due diligence of potential acquisitions by the company, and improving existing processes.

Previously, Paul held various roles at Biogen Corporation and Genzyme, a Sanofi Company, where he honed his expertise in clinical asset planning and clinical supplies management. His contributions to these organizations included serving as a lead contact for multiple clinical programs, developing supply chain strategies, leading continuous improvement projects, and serving as Fellowship Coordinator and Student Preceptor for dozens of students.

Paul has a BS in Biology from Providence College, PharmD from MCPHS Boston, and an MBA from Worcester Polytechnic Institute. He also completed a Post-PharmD Industry Fellowship in Clinical Research/Investigational Product Management with MCPHS-Worcester and Genzyme Corporation. He is Chair of the Dean's Advisory Board at MCPHS School of Pharmacy – Boston,  a member of the Pharmacy Advisory Board at Western New England University, and a member of the Advisory Board for the Clinical Trial Supply global conference series.

Session Details:

Chairperson’s opening remarks

2026-04-15, 8:50 AM

Session Details:

Panel Discussion Building cross-functional alignment to navigate global trade challenges in clinical supply

2026-04-14, 11:00 AM

Session Details:

Chairperson’s opening remarks

2026-04-14, 8:50 AM

Session Details:

Chairperson’s closing remarks

2026-04-15, 4:00 PM

Session Details:

PANEL DISCUSSION Implementing best practices for outsourcing services through third party vendors

2026-04-14, 5:00 PM

Session Details:

Panel Discussion Leveraging AI and digital tools to future-proof clinical supply

2026-04-15, 3:15 PM

View In Agenda
Next

Plan Your Visit

Venue

The Westin Waltham Boston

70 Third Avenue Waltham MA 02451 US

/iframe>

Accommodation

Arena International Events Group “(Arena”) is aware of numerous third-party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings, events attendee lists and selling unsolicited services. It is unclear whether the agencies in question are in possession of such information, or whether they intend to scam unsuspecting customers. Whilst Arena International Events Group pursues such third-party companies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third-party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group..

2026 Sponsors

Select a sponsor to learn more

FEATURED SPONSORS

TECHNOLOGY SPOTLIGHT

EXHIBITORS

Why partner?

Contact us to become a partner

Partnership Opportunities

We work with you to design a bespoke package to meet your business needs, where you could:

  • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
  • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
    Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
  • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

Event reach

  • 150+ attendees each year
  • 80% attendees C-suite level

 

Take a look at our current sponsors

Media Centre

Enquiry

Contact Us

SPONSORSHIP ENQUIRIES

Jaz Sidhu

Senior Sponsorship Manager

+44 (0) 207 9472755

SPEAKING OPPORTUNITIES

Ruth Atterbury

Clinical Trial Supply Portfolio Manager

MARKETING ENQUIRIES

Moona Popal

Marketing Manager

DELEGATE ENQUIRIES

Sunny Saikia

VIP Delegate Manager

Sponsorship Enquiries

To enquire about sponsorship opportunities for the conference, please contact:

 

Jaz Sidhu

Senior Sponsorship Manager


+44 (0) 20 7947 2755

Speaker Enquiries

To enquire about speaking opportunities for the conference, please contact:

 

Ruth Atterbury

Clinical Trial Supply Portfolio Manager